Worldwide Initiative for Device Equity (WIDE)

The Problem: Every year, the FDA authorizes more than a thousand new medical devices. Small companies drive the majority of this innovation. Very few of these reach technologies reach low and middle-income countries, even ones designed for these settings.


Breaking Market Barriers

Our unique approach reduces market entry costs by creating efficient regulatory pathways across multiple LMIC countries for innovative medical devices from small companies.

Accelerating Global Impact

We fast-track the journey of breakthrough medical technologies from FDA approval to successful sales and implementation in emerging markets.

Maximizing Health Impact

We ensure lasting impact by integrating training, maintenance, and financial sustainability into every medical device implementation plan worldwide.

How We Work

Focus on Small Innovators

We identify emerging medical device companies and startups with high-impact solutions that recently received FDA clearance.

Bundled Regulatory Clearance

We group promising devices and have a centralized expert regulatory team establish market entry across multiple LMIC countries.

In-Country Access Team

We go beyond sales and distribution by providing ongoing training, support, and maintenance to maximize device utility.